Recent FDA approvals for immunotherapy drugs for treating lung cancer are exciting, but there still are many things we need to learn about this new field of cancer treatment. Cancer.Net Associate Editor Jyoti Patel, MD, answers some of the questions that surround lung cancer and immunotherapy, during Lung Cancer Awareness Month.
ON THIS PAGE: You will find out more about screening for this type of non-small cell lung cancer (NSCLC). You will also learn the risks and benefits of screening. Use the menu to see other pages.
Screening is used to look for cancer before you have any symptoms or signs. Scientists have developed, and continue to develop, tests that can be used to screen a person for specific types of cancer. The overall goals of cancer screening are to lower the number of people who die from the disease or eliminate deaths from cancer altogether.
ON THIS PAGE: You will find out more about screening for small cell lung cancer. You will also learn the risks and benefits of screening. Use the menu to see other pages.
Screening is used to look for cancer before you have any symptoms or signs. Scientists have developed, and continue to develop, tests that can be used to screen a person for specific types of cancer. The overall goals of cancer screening are to:
Lower the number of people who die from the disease, or eliminate deaths from cancer altogether
ON THIS PAGE: You will find some basic information about this disease and the parts of the body it may affect. This is the first page of Cancer.Net’s Guide to Small Cell Lung Cancer. Use the menu to see other pages. Think of that menu as a roadmap for this entire guide.
Lung cancer affects more than 200,000 people in the United States each year and an estimated 2.3 million people worldwide each year. About 10% to 15% of people with lung cancer have a type called small cell lung cancer.
Patient advocate Diana Chingos wanted to attend the 2015 ASCO Annual Meeting to learn about the latest cancer research. After four intense days of posters and presentations, she left Chicago with a mountain of new knowledge and four key insights.
In this podcast, experts discuss ASCO’s recent endorsement of ASTRO’s guideline for radiation therapy for non-small cell lung cancer.
What would it be like to meet the inventor of the investigational drug that is keeping you alive? Janet Freeman-Daily found out firsthand at the 2014 ASCO Annual Meeting.
Submitted by ascoadmin on
ON THIS PAGE: You will find descriptions of the most common types of cancer of unknown primary (CUP) tumors. Use the menu to see other pages.
The subtypes of CUP describe the type of tumor found in the body. These subtypes are identified by the pathologist when the tumor biopsy is examined under the microscope. Knowing the subtype can help the doctor recommend what kind of treatment is best, and it can help predict a patient's prognosis, which is the chance of recovery.
